5G6-57582-32989
3 vaccinations
0 coded responses
14 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-12
Registered in v-safe
-
2021-02-12
Health check-in — day 7, dose 2Feeling: Good · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-12
Report sent to call center — day 7, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-05
-
2021-09-29
Dose 3 — Pfizer-BioNTech
- 2021-10-02
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-12 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.